510(k) Report

PMA · Approved

Approved

IsoPSA Assay

P200048PMAApproved Nov 28, 20251,796-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cleveland Diagnostics, Inc. · QRF Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer

Approved on Nov 28, 2025 through premarket approval, which rests on the device’s own clinical evidence after a 1,796-day review.

Decided
Nov 28, 2025
Review
1,796 days
Class
Class III
Product code
QRF
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P200048 has 1 supplement since 2026: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2026: 1
2026high 1 (2026) · low 0 (2027)2027
View FIG. 1 as a table
YearSupplements approved
20261
FIG. 1 — Supplements to P200048, 2026–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QRF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All QRF devices

QRF Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · QRF

2in 2025

2021: 12024: 22025: 22026 (partial year): 1
2007high 2 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QRF

Too few QRF 510(k)s in any year since 2007 to give a median.

Recalls per year · QRF

1in 2023

2023: 1
2007high 1 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QRF

371in 2023

2023: 371
2007high 371 (2023) · low 0 (2007)2025

MAUDE reports naming product code QRF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20211—00
20220—00
20230—1371
20242—00
20252—00
20261—0—
Cite this page

510(k) Report. “P200048: IsoPSA Assay.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/P200048

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026